Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
A share? LOL, rather put the money into RXSF or RXMD! LOL.
Hey SkiLuc, long time brother! Hope thing are going well for you and your family!!!!!
Whats up with SMME? 15 years, no products, no revenues? Whats up with that?
RXMD is an undervalued bricks and mortar company.............great pick Cheeky!!
Cheeky....can I have some of those sticks?
RXSF Q should have a great reveal in it........better late than never.........bet you our gal CEO has a great shareholder update right after that!!!!
RXMD - Great little stock, great bricks and mortar company, has several physical pharmacy locations, barely any debt, looking good!!!!!!
I love judgement free zones, has anyone figured out how NXTD stays on NASDAQ when its below .50 for like....an eternity? All they do is dilute the shareholders with huge convertible fundings, and THEY get to stay on NASDAQ, unbelievable
I like RXSF, RXMD. SMME and NXTD. All healthcare/biometric related stocks.
Not true, I will make some money too!
Me? I OWN 25K shares and I'm holding. I said give it some time and lets see what happens AFTER I brought up issues about disclosures. I didn't write the PR's or the SEC Q's and K's.
Holy crap.....I missed the "IPO" that the "SEC" approved. Damnit. Still holding onto my 25K shares with a Kung Fu grip!
"All the right steps" is a matter of perspective. An outsider "may" have tried to do things differently but without the benefit of the knowledge that management has, its an opinion, nothing more. Those who don't see insiders selling, don't see huge amounts of conversions slamming the markets, those who recognize sales initiatives have just started and revenues are starting to be booked, those who recognize that the company is following steps it had announced over the months....see progress already. There is no need to wait to try to find a smoking gun, when its already been proven to not exist. The great thing is everyone has an opinion, but until we step into shoes of management and understand why things were done the way they were, we will never know. We can only look at results. Other than the toxics, which may have been a temporary necessary evil, I don't see much wrong otherwise.
I am AGAIN limited to one post a day, so it will be easy to rebuff this post with not much feedback from me. But I will be back tomorrow, and the next day, and the day after that as well.
And I can agree with your view of things. But when only half the story is told, that can be misleading.But if you are providing your opinion, you do NOT have a monopoly on that. Others can express their opinions based on disclosures and facts as well. And the purpose of this board is for discussing RXSF, and that means everything about RXSF, all sides, and reasons for taking sides.
Stock didn't surge either time. Put up the proof. In fact, the $10M ELOC caused a massive stock price fall. Go back and look at the charts and dates.
Well if THATS how your posts came across, I would say thats a fair opinion to have. They haven't been. There is a reason this company uses social media besides its regulatory filings. Its to inform shareholders. If that was a good analysis, then any regulatory filing (required disclosures) are ALL PUMPS.
The ONLY type of pump I am concerned about is paid pumps.. Not good.
And please provide us with your account of "failure". Not sure what you mean by using that term.
Well, obviously there is a complete breakdown in understanding and what's said will matter less and less as the company progresses. Certain DD or "selected DD" can create a picture and usually does influence typical trading in OTC companies that are thinly traded. I think it will be less relevant as the company progresses.
I am interested to see who the banker is and what the plan is. That will tell me more than any post here.
Excuses for shareholders who bought at the pump? Please explain this to the board. What I see disclosed is the stock rising post split when Kodiak caused a $5m fraudulent loss of market cap to the company. You would first have to read the complaint to see the nature and extent of the fraud. That should help you understand there was no pump. Just market reactions after the fraud, to public disclosures and unauthorized and quite possibly illegal conversions and SAWA by Kodiak. This should get interesting as we all await your DD.
Commitment to financings mean absolutely nothing because of all of the built in contingencies every banker has built in. What's more important is the quality of the banker, the level of activity that banker contracts to get involved with the company and the feasibility of any financing plan. A lot of day traders don't see the bigger picture but us longs do. As much as cherry picked DD can draw a picture it's always good to look at the bigger picture. Hopefully we find out this week. Should be interesting.
Seems there is a lot of confusion on your part. The $1m order from the grant was cancelled because Advicare failed to qualify for it. Not RXSF. The $10m financing last year was a toxic equity line requiring an S1 that was with Coventry and cancelled more than a year ago as wel. Not sure why there is so much confusion on your part. DD and reading the disclosures show this information was made public to shareholders a year ago.
Why post news from last year when it was already disclosed that the underlying not for profit failed to qualify under the grant. Everyone else here knows this. Simple DD would have revealed this. Simple stuff.
Again, real bankers may consider toxic debt if it substantially impacts a raise, meaning that they would have to continue to deal with the toxic debt after the raise. And maybe, if the company had $5M in toxic debt, it would matter, but please, $500-$600K in toxic debt is a check away from $0.00 liabilities. Some here assume that the company and its bankers would have to continue to deal with toxic debt, and then price a deal way below market, well.....thats exactly the implication that some are making anyway. Considering shareholder equity, toxic debt will be the first thing that gets retired, just like the CEO has been saying all along. That hasn't changed.
Again, its what "investors" deem necessary to invest in. Day guys and OTC retailers look only at 2 things, PPS and volume. Thats what they do, and thats all they base investment decisions on. Its nothing more than a stock play to them. They ONLY want to know the company has longevity enough to liquidate their stock, they couldn't care less about the company or its shareholders. We will need to see what the plan going forward looks like, but I have a feeling, again, PPS and volume are the LAST things on their minds, because down here in the OTC cesspool, they don't play, so don't care.
Real investors, the ones that invest and don't sell within 2 years on NASDAQ and NYSE, invest in enterprise value, which considers a lot of actual business metrics, both current, but for large PO type investment, based on future value. Granted, it appears those not invested see this as a big OTC game and are really shooting from the hip based on misinformation or worse. And to them doesn't matter if the stock tanks because they are only invested in online discussions. The nonsense bickering back and forth about toxic debt, whats credible or not, while entertaining, is based solely on speculation, and to some, thats fun, engaging in a battle of wits trying to come up with that nugget to prove, or disprove a future event. What a waste of time.
Hopefully to sell. I think the float is going to need it.
What? NO WAY. Too much toxic debt. Little sales. Pumps. We will see. Analysis has been its not fundable because the PPS keeps going down. PPS. PPS. PPS. Keep repeating. PPS. Toxic Debt. PPS. Pump and Dump. Conversions. Guess we will all be getting a lesson. Lol.
Please. If and when the company announced its banker and its funding roadmap, we will all end doing a jig
No, the toxic debt DOES exist, but its not having the impact you are trying to get across. Its controlled, the lack of market interest is whats hurting the PPS, but from what I hear, those who think money is coming in based on PPS will be in for a very rude awakening. I already told you what sophisticated NASDAQ/NYSE Bankers use to value company, and its NOT, nor anything to do with, PPS. Thats a trader thing, not a real investment banker thing, and only on the OTC. And rushing sales is not going to help anyone. I am sure when the company is properly funding and can spend money on marketing and sales, it will do just fine, as is evidenced with orders already placed without any effort in those markets. I am sure Lorraine will release a shareholder update after the Q, because the Q will only show you what happened Q1, not last week. Her updates are informative, so get your pencils ready so you can CHECK OFF the boxes next to the statements and objectives she has been saying for the last couple of months.
Takes time to do things the right way to cover all bases.
Well we will soon see who the banker is and what they will be doing for the company. Until then it's ALL speculation and opinion.
It will be nice if and when the company finally announces what is happening to give shareholders a real tangible roadmap. I agree, the Q1 will be unimpressive simply because I believe everything has happened Q2, thats why I will basically focus on "Subsequent Events" in the Q1, because thats where the company can discuss what has happened after March 31. I am interested to see how the several notes that came due Q1 were handled. I can tell a few of them have been retired, but would like to hear from the company directly in its disclosure. We already know 2 notes were converted and subject to leak out provisions. But any discussions on those notes, and any new notes, should be done with an eye on how they were, or will be handled in the future, so there has to be some news about a plan to retire them. Lorraine has said since November that she wanted to retire them in one shot with new financing, financing that seemed to have been in place with KODIAK until they committed their fraud. I am guessing she was forced to wait to get beyond that issue before re-engaging a new banker. I am also interested to see disclosed the plan with the new banker. I have a feeling that all this time that has passed was caused by careful analysis, the formation of a comprehensive financing plan and DD by the banker to even take on an OTC company. I know that could take months, so hopefully the company passed muster.
I think the next few disclosures will move this conversation from toxic debt to what will Lorraine wear at the opening bell.
I would bet those 4000 shares were picked up ahead of the high bids to cover sales of stock the MM's sold but didn't have. Probably more of a reconciliation book entry from its market making activities. The high bidders only were partially filled, and that seems to be what happened. If the MM's were covering for shares they really didn't have, they could not deliver those shares so they jumped ahead and covered first. They are allowed to do that. Short report almost averaging 70% per-day, playing for .25 cent spreads. Unheard of for this long. But the MM's are making a nice profit selling and then covering.
Or, someone sold actual shares but the MM's still had to cover its shorts (and may have a LONG way to go), so when real shares showed up, they had a chance to cover and filled themselves first, again, they are allowed to do that. Either way, for those high bidders who were't filled but saw that 4,000 block go off, those are the only 2 explanations, and they all point back to the MM. Nothing more.
Just my opinion, but piling up bids .20 off the ASK does nothing but foster this type of MM activity. They ONLY play for the spread, thats what they are built for, and thats the only way they make money. The larger the spread, the bigger the gains and the worse the game.
DD is an important part of investing, but in the end, you have to like something , whether its the CEO, the product, the technology, the size and scope of the problem addresses, etc.......and one of those reasons is why I had bought 25K shares, and I will be holding them. There is always a chance things will work out with any OTC company, and SMME is no different, and this coming from someone who knows the industry and the markets. Its TOUGH.
Every company has its champions, and I am fortunate that my investments have theirs, including here. I also appreciate DD that seems to get lost in hype, and ALL OTC companies suffer this as well. It sometimes appears harsh, but it remains a stark reminder the challenges faced by undercapitalized companies to move forward trying to break new ground.
For those reasons, SMME gets an "A" so far for effort. As hard as I have been, it was a reminder to the board, and myself, how hard it actually is. Hopefully management here is watching, and maybe can make some adjustments doing a better job disclosing in the future, because if its truly as close as stated, it could only serve SMME and its shareholders. YD said something on another board that has stuck with me for months.....when a company makes a mistake.....acknowledge it, learn from it, and do a better job in the future. This could be a new chapter for SMME, but thats up to the CEO, not me. I've learned from past mistakes you don't always get a chance to reboot- and when you do -seize the opportunity. GLTA here!
And YD is 100% correct - we usually sit on opposite sides, but I completely respect his opinions and his acute ability to dig into disclosures and "balance" things out. I suggest you look at his DD as a learning tool rather than a negative, because learning from mistakes, improves the process going forward.
There are many challenges facing companies, especially on the OTC, when attempting to develop new products to solve problems costing billions in losses a year. All of them involving finance. Every company and every CEO has different approaches and not everyone can agree on which is right or wrong. Only success or failure will measure whether the approach being taken is the right one.
I believe the core focus of SMME is a good and needed one. While I may not agree how its getting there, the hope is that they do. CC fraud is a big problem, and if SMME has developed a working solution, more power to it.
I can only wish long shareholders here good luck and hope that this venture works out - because this is one of those products the economy needs.
Whats even sadder, is that the government gives hundreds of millions of dollars a year to these non-profits to pay for educational materials and programs that are simply failing. They are not preventing teens from experimenting with drugs. In fact, for the last 15 years, the numbers get worse. On the other side, you have the DOJ drug "take-back" programs, which, if you ask me, is a subterfuge for the EPA so drugs don't get into the waterways. Both programs are good, but do not address the REAL issue. People need these medications, so what do you do with them when they are in the house?
All states have laws requiring locking up a handgun in a metal safe, under lock and key. I know the company is working with several state legislatures to enact similar legislation starting with the worst states. If you do your DD, 70% of all teens (12-17) experiment with prescription drugs and they get them from the family, or friends, medicine cabinets. 98% of all households do NOT lock up their meds.
This company focuses its technology and efforts on one thing - to secure and administer controlled substances in a safe and effective manner that can be monitored. Its one of the only companies to do this on both the consumer and professional healthcare levels.
If you don't like the company, or the stock, just move on. The more this is held down, the lesser effect it will have in helping to curtail drug abuse. Sometimes we all forget the severity of the problem that this company is trying to address. And its a life and death problem, in many ways.
Lots of talk about destructive issues here....toxic debt.....paid pumps.......even Twitter (LOL), but the REAL destructive issues are drug abuse and getting in the way of trying to stop it.
From what I see, management and its main shareholder group do not look at this as a stock play. They are taking this very seriously, or you would have seen many Form 4's selling stock. They all agreed to lock up for more than a year, yet some only see this as a stock play. Its not, its much, much more. I suggest if you understand the drug problem and how bad it is and how it affects not just the addict, but family and friends as well, that you start focusing your DD on solutions and the future.
The only paid pump done with this stock was done last summer by a third party that bought debt. Other than that, there have been no paid pumps. I can say those words too.......
TOXIC DEBT.....PAID PUMP.........TOXIC DEBT............PAID PUMP...........
Its as if the more its said, the more people will think its true......thats taken from a liberal political playbook called Rules for Radicals by Saul Alinsky written in the 60's and was a 40 years plan to slowly take away citizens rights and property. One of the main tactics is to keep saying false things over and over and over again, and soon, people will start believing it and changing their views.
This principle has been applied to stocks as well....spread misinformation as truth based on 1 little point of fact............ to the exclusion of other facts that further define those words.
Its not going to work here because the company has been transparent, has been accomplishing everything so far it said it would do, and there is absolutely NO INDICATION or FACT that it won't continue to.............
but let's all chime in for a chorus because this is fun.......
TOXIC DEBT.....PAID PUMP........TOXIC DEBT..........PAID PUMP..............
is it true yet? LOL
This board is an interesting read. Its like a bunch of wine enthusiasts on a wine tour, and they get to a boutique winery, read about how the wine was just made a few months ago and that the owners of the winery have said the wine has to go through a process, allowing the wine to develop in its casks before sampling it, and suggests if you buy a bottle or two, don't open it for a few months. So some look at the casks without buying a bottle, and say, "this wine sucks, the weather was terrible for the grapes, the ground wasn't moist enough, and no matter what you do, the wine is just going to suck". Other aficionados buy a few bottles, even after hearing what the others had to say, and take the wine home with them, because they know wine takes time to develop and cure before it reaches optimum flavor.
Now everyone on the tour became friendly, so a few days later, the guys who bought the wine and took it home are now getting calls from the ones that didn't buy the wine, telling them, did you try it yet, I told you it would suck, go ahead and open it, don't listen to the owners, open it and try it, go ahead, its going to suck just as much now as it will in a few months, so you might as well just try it, because I told you it would suck, I told you the weather was bad, that the ground wasn't moist enough, go ahead, just open it NOW and you will see we are right.
So a few of the buyers fell into the non-buyers trap, and opened the wine too early, and it was a terrible taste, and they called back the non-buyers and said we never should have bought this wine, you were right, it sucks.
A few months later, some of the other purchasers got a call from the wineries owner that told them it was alright to open the wine now, because it has matured and reached its full potential. That the grapes needed to ferment and it should be good now. That same week, the 2016 Wine Report came out and said that it just tested the wine, and it was rated top in al categories. So they all opened the wine and took a sip, and then they wondered..................so they called their friends, the other purchasers, and told them how wonderful the wine tasted and that it won many awards, and how did they like theirs, and they said, we listened to those assholes, and opened it too soon, and it sucked..........but they were right. It sucked at the moment they opened it prematurely and didn't allow the fermenting process to be completed.
Whats in your wine rack?
The I will say I was wrong. Simple as that.
Yes, I believe the CEO already explained that at the time in 2008, their prior company lost an $8M funding when the economy crashed and the 3 executives sold stock and put it back into the company to pay employees and payroll taxes. This is very old news.
So in the last 6 years, can you point to a Form 4 or a Rule 144 Notice of Sale in this company?
As a matter of fact, those 3 executives also personally guaranteed millions in manufacturing loans as well as put in over $1M each into that company. Thats called RESPONSIBILITY, LOL, something other companies can learn from.
But I suggest you call Lorraine and ask her directly. Her number is at the company website. LOL.
Progress is taking $25M and turning that into a products that drives revenues in 3 years. Sorry, it doesn't take 15 years - and now, you can simply get off the shelf parts made in China, Taiwan and Japan (even Germany and Italy) and create something that does the same thing. I think the idea here was to develop the technology first, before ANYONE else can, and get it into the market. There is no unique software or back end integration needed, because the Chip itself already has a standard platform within which it is required to operate, and all biometric chipsets come with matching algorithms. The BIG claim to fame here was, that the CEO (laughable) miniaturized all of the necessary components to fit within a standards cards physical dimensions..... and that took 15 years? SMME claimed that it developed the "worlds smallest finger sensor" years ago. The disclosures don't show the money necessary to dedicate to the engineering, and thats why I suggested last year, she is using someone else's sensor. Haven't been proven wrong yet. Authentec took 3 years and $120M to develop its finger sensors before Apple acquired them. Same costs and development time with Atrua. I already supplied links to companies that now have all of those component technologies you can piece together to put a biometric scanner on a card. Prove me wrong. This is what we get with an inexperienced CEO who has funded a 15 years science project on the backs of shareholders while living the good life. Go figure.......
I want to see a working card, but when given the right venue and opportunity to demonstrate it, SMME "chose" not to, but they did "show" the card. Its all smoke and mirrors unless we see a card working, and even now if it does, the card issuers will be doing a cost analysis on whether they can just hire an engineering form to slap them together, or SMME would supply. But another huge obstacle......VISA nor MC will allow SMME to fund manufacturing based on their orders. No, SMME will have to raise about $40M to guarantee back the ability and quality of the product if SMME even gets that far. Based on how this CEO pirates, its doubtful to me at best.